27 related articles for article (PubMed ID: 34476882)
1. Australian breast surgeons and ultrasound usage: Have practices changed?
Bennett I; Khoo JF; De Viana D; Law M
Australas J Ultrasound Med; 2021 Nov; 24(4):217-224. PubMed ID: 34888131
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for breast cancer in patients with schizophrenia.
Hwang M; Farasatpour M; Williams CD; Margenthaler JA; Virgo KS; Johnson FE
Oncol Lett; 2012 Apr; 3(4):845-850. PubMed ID: 22741004
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer care and surgery in Australia and New Zealand: compliance of the BreastSurgANZ quality audit with international standards.
Duffield JA; Blanch AJ; Bochner MA
ANZ J Surg; 2023 Apr; 93(4):881-888. PubMed ID: 36856199
[TBL] [Abstract][Full Text] [Related]
4. Male Breast Cancer in Australia.
Lomma C; Chan A; Chih H; Reid C; Peter W
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e57-e62. PubMed ID: 31957255
[TBL] [Abstract][Full Text] [Related]
5. What are the appropriate thresholds for High Quality Performance Indicators for breast surgery in Australia and New Zealand?
Salindera S; Ogilvy M; Spillane A
Breast; 2020 Jun; 51():94-101. PubMed ID: 32252005
[TBL] [Abstract][Full Text] [Related]
6. Prospective Evaluation of the Impact of the 21-Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node-Positive Breast Cancer in Ontario, Canada.
Torres S; Trudeau M; Gandhi S; Warner E; Verma S; Pritchard KI; Petrella T; Hew-Shue M; Chao C; Eisen A
Oncologist; 2018 Jul; 23(7):768-775. PubMed ID: 29371476
[TBL] [Abstract][Full Text] [Related]
7. BreastSurgANZ members recommendations for adjuvant systemic treatment and patient compliance in Australian breast cancer patients.
Chan A; O'Neil N; Lomma C; Chih H; Willsher P
ANZ J Surg; 2021 Nov; 91(11):2418-2424. PubMed ID: 34476882
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals.
Barthélémy P; Heitz D; Mathelin C; Polesi H; Asmane I; Litique V; Rob L; Bergerat JP; Kurtz JE
Crit Rev Oncol Hematol; 2011 Aug; 79(2):196-204. PubMed ID: 20655243
[TBL] [Abstract][Full Text] [Related]
9. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
[TBL] [Abstract][Full Text] [Related]
11. The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease.
Sammons S; Sedrak MS; Kimmick GG
Drugs Aging; 2020 May; 37(5):331-348. PubMed ID: 32100240
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
